Literature DB >> 16372054

Pregabalin: the next new thing.

Edward Faught.   

Abstract

Year:  2005        PMID： 16372054      PMCID： PMC1312736          DOI： 10.1111/j.1535-7511.2005.00068.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

1.  Placebo effect in antiepileptic drug trials.

Authors:  Jorge G Burneo; Victor M Montori; Edward Faught
Journal:  Epilepsy Behav       Date:  2003-06       Impact factor: 2.937

Review 2.  New antiepileptic drugs: comparison of key clinical trials.

Authors:  J A Cramer; R Fisher; E Ben-Menachem; J French; R H Mattson
Journal:  Epilepsia       Date:  1999-05       Impact factor: 5.864

3.  Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.

Authors:  A Beydoun; B M Uthman; A R Kugler; M J Greiner; L E Knapp; E A Garofalo
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

4.  Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.

Authors:  J A French; A R Kugler; J L Robbins; L E Knapp; E A Garofalo
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

5.  Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.

Authors:  Santiago Arroyo; Henning Anhut; Alan R Kugler; Caroline M Lee; Lloyd E Knapp; Elizabeth A Garofalo; Silke Messmer
Journal:  Epilepsia       Date:  2004-01       Impact factor: 5.864
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.